Impact of Systemic Anti-Her2 Treatment on Overall Survival in Patients With Brain Metastases From Her2-overexpressing Breast Cancer

被引：1
|
作者：
Bartsch, R. [1 ,2 ]
Berghoff, A. [1 ,2 ]
Pluschnig, U. [1 ,2 ]
Bago-Horvath, Z. [3 ]
Dubsky, P. [4 ]
Rottenfusser, A. [5 ]
Gnant, M.
Mader, R. [1 ,2 ,4 ]
Zielinski, C. C. [1 ,2 ]
Steger, G. G. [1 ,2 ]
机构：
[1] Med Univ Vienna, Dept Med 1, Vienna, Austria
[2] Med Univ Vienna, Ctr Canc, Vienna, Austria
[3] Med Univ Vienna, Dept Pathol, Vienna, Austria
[4] Med Univ Vienna, Dept Surg, Vienna, Austria
[5] Med Univ Vienna, Dept Radiotherapy, Vienna, Austria
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)71503-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S348 / S348
页数：1
相关论文
共 50 条
  • [1] Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases
    Bartsch, R.
    Berghoff, A.
    Pluschnig, U.
    Bago-Horvath, Z.
    Dubsky, P.
    Rottenfusser, A.
    DeVries, C.
    Rudas, M.
    Fitzal, F.
    Dieckmann, K.
    Mader, R. M.
    Gnant, M.
    Zielinski, C. C.
    Steger, G. G.
    BRITISH JOURNAL OF CANCER, 2012, 106 (01) : 25 - 31
  • [2] Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases
    R Bartsch
    A Berghoff
    U Pluschnig
    Z Bago-Horvath
    P Dubsky
    A Rottenfusser
    C DeVries
    M Rudas
    F Fitzal
    K Dieckmann
    R M Mader
    M Gnant
    C C Zielinski
    G G Steger
    British Journal of Cancer, 2012, 106 : 25 - 31
  • [3] Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival
    Yap, Y. S.
    Cornelio, G. H.
    Devi, B. C. R.
    Khorprasert, C.
    Kim, S. B.
    Kim, T. Y.
    Lee, S. C.
    Park, Y. H.
    Sohn, J. H.
    Sutandyo, N.
    Wong, D. W. Y.
    Kobayashi, M.
    Landis, S. H.
    Yeoh, E. M.
    Moon, H.
    Ro, J.
    BRITISH JOURNAL OF CANCER, 2012, 107 (07) : 1075 - 1082
  • [4] Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival
    Y S Yap
    G H Cornelio
    B C R Devi
    C Khorprasert
    S B Kim
    T Y Kim
    S C Lee
    Y H Park
    J H Sohn
    N Sutandyo
    D W Y Wong
    M Kobayashi
    S H Landis
    E M Yeoh
    H Moon
    J Ro
    British Journal of Cancer, 2012, 107 : 1075 - 1082
  • [5] Treatment of HER2-overexpressing breast cancer
    Baselga, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 36 - 40
  • [6] STEREOTACTIC RADIOSURGICAL TREATMENT MIGHT PROLONG SURVIVAL OF HER2-OVEREXPRESSING BREAST CANCER PATIENTS WITH PARENCHYMAL BRAIN METASTASES
    Xu, Zhiyuan
    Navaratne, Kapila
    McGraw, Mary V.
    Weil, Robert John
    NEURO-ONCOLOGY, 2009, 11 (05) : 692 - 693
  • [7] Brain metastases in HER2-overexpressing metastatic breast cancer (MBC) patients (PTS)
    Gori, S.
    Rimondini, S.
    De Angelis, V.
    Sidoni, A.
    Mosconi, A. M.
    Aristei, C.
    Perrucci, E.
    Basurto, C.
    Franceschi, E.
    Scopece, L.
    Degli Esposti, R.
    Colozza, M.
    Crino, L.
    ANNALS OF ONCOLOGY, 2005, 16 : 10 - 11
  • [8] A case with HER2-overexpressing breast cancer completely responded to humanized anti-HER2 monoclonal antibody
    Ohta, M
    Tokuda, Y
    Suzuki, Y
    Kubota, M
    Watanabe, T
    Fujii, H
    Sasaki, Y
    Niwa, T
    Makuuchi, H
    Tajima, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (11) : 553 - 556
  • [9] In vitro assessment of the effects of anti-HER2 monoclonal antibodies on proliferation of HER2-overexpressing breast cancer cells
    Tahmasebi, Fathollah
    Kazemi, Tohid
    Amiri, Mohammad Mehdi
    Khoshnoodi, Jalal
    Mahmoudian, Jafar
    Bayat, Ali Ahmad
    Jeddi-Tehrani, Mahmood
    Rabbani, Hodjatallah
    Shokri, Fazel
    IMMUNOTHERAPY, 2014, 6 (01) : 43 - 49
  • [10] Lapatinib for the treatment of HER2-overexpressing breast cancer
    Jones, J.
    Takeda, A.
    Picot, J.
    von Keyserlingk, C.
    Clegg, A.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 1 - 6
12345